FDA Clears CoAlign Innovations’ AccuLIF Interbody Fusion Devices to Market

Redwood City, Calif.-based CoAlign Innovations received FDA market clearance for the AccuLIF XL lateral expandable interbody fusion device line.

Advertisement

The product line includes the AccuLIF TL for TLIF procedures and the AccuLIF PL for PLIF procedures. The systems are designed to be low profile with controlled expansion for precise anatomical reconstruction.

More Articles on Devices:
Smith & Nephew Allowed to Promote KFx Medical Rotator Cuff Repair Device
Australian Government Warns of LMT Surgical’s Arthroplasty Device Safety
Stryker Awarded $85.5M DOD Contract for Hip, Knee Implants

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.